Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

680 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT).
Kobayashi Y, Shimada M, Tamate M, Cho HW, Zhu J, Chou HH, Kajiyama H, Okamoto A, Aoki D, Kang S, Lee JW, Kim JW, Kim JH, Lin Z, Liu J, Wu X, Lai HC, Chang TC, Lai CH, Kim YM, Enomoto T. Kobayashi Y, et al. Among authors: aoki d. J Gynecol Oncol. 2024 Apr 3. doi: 10.3802/jgo.2024.35.e87. Online ahead of print. J Gynecol Oncol. 2024. PMID: 38606827 Free article. No abstract available.
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.
Kikuchi Y, Shimada H, Yamasaki F, Yamashita T, Araki K, Horimoto K, Yajima S, Yashiro M, Yokoi K, Cho H, Ehira T, Nakahara K, Yasuda H, Isobe K, Hayashida T, Hatakeyama S, Akakura K, Aoki D, Nomura H, Tada Y, Yoshimatsu Y, Miyachi H, Takebayashi C, Hanamura I, Takahashi H. Kikuchi Y, et al. Among authors: aoki d. Int J Clin Oncol. 2024 May;29(5):512-534. doi: 10.1007/s10147-024-02497-0. Epub 2024 Mar 17. Int J Clin Oncol. 2024. PMID: 38493447
Polycyclic aromatic hydrocarbons in samples of Ryugu formed in the interstellar medium.
Zeichner SS, Aponte JC, Bhattacharjee S, Dong G, Hofmann AE, Dworkin JP, Glavin DP, Elsila JE, Graham HV, Naraoka H, Takano Y, Tachibana S, Karp AT, Grice K, Holman AI, Freeman KH, Yurimoto H, Nakamura T, Noguchi T, Okazaki R, Yabuta H, Sakamoto K, Yada T, Nishimura M, Nakato A, Miyazaki A, Yogata K, Abe M, Okada T, Usui T, Yoshikawa M, Saiki T, Tanaka S, Terui F, Nakazawa S, Watanabe SI, Tsuda Y, Hamase K, Fukushima K, Aoki D, Hashiguchi M, Mita H, Chikaraishi Y, Ohkouchi N, Ogawa NO, Sakai S, Parker ET, McLain HL, Orthous-Daunay FR, Vuitton V, Wolters C, Schmitt-Kopplin P, Hertkorn N, Thissen R, Ruf A, Isa J, Oba Y, Koga T, Yoshimura T, Araoka D, Sugahara H, Furusho A, Furukawa Y, Aoki J, Kano K, Nomura SM, Sasaki K, Sato H, Yoshikawa T, Tanaka S, Morita M, Onose M, Kabashima F, Fujishima K, Yamazaki T, Kimura Y, Eiler JM. Zeichner SS, et al. Among authors: aoki d. Science. 2023 Dec 22;382(6677):1411-1416. doi: 10.1126/science.adg6304. Epub 2023 Dec 21. Science. 2023. PMID: 38127762
Impact of COVID-19 on gynecological cancer incidence: a large cohort study in Japan.
Komatsu H, Ikeda Y, Kawana K, Nagase S, Yoshino K, Yamagami W, Tokunaga H, Kato K, Kimura T, Aoki D, Obstetrics TCOGOOTJSO, Gynecology. Komatsu H, et al. Among authors: aoki d. Int J Clin Oncol. 2024 Jan;29(1):72-77. doi: 10.1007/s10147-023-02431-w. Epub 2023 Dec 6. Int J Clin Oncol. 2024. PMID: 38055097
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Oaknin A, Gladieff L, Martínez-García J, Villacampa G, Takekuma M, De Giorgi U, Lindemann K, Woelber L, Colombo N, Duska L, Leary A, Godoy-Ortiz A, Nishio S, Angelergues A, Rubio MJ, Fariñas-Madrid L, Yamaguchi S, Lorusso D, Ray-Coquard I, Manso L, Joly F, Alarcón J, Follana P, Romero I, Lebreton C, Pérez-Fidalgo JA, Yunokawa M, Dahlstrand H, D'Hondt V, Randall LM; ENGOT-Cx10–GEICO 68-C–JGOG1084–GOG-3030 Investigators. Oaknin A, et al. Lancet. 2024 Jan 6;403(10421):31-43. doi: 10.1016/S0140-6736(23)02405-4. Epub 2023 Dec 1. Lancet. 2024. PMID: 38048793 Clinical Trial.
680 results